Transaction DateRecipientSharesTypePriceValue
25th March 2019Heather Raines50,000Grant/award etc.$0.00
Provectus Biopharmaceuticals
Provectus Biopharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.


Provectus Biopharmaceuticals, Inc. was founded by Eric A. Wachter in 2002. Its prescription drugs treats several life threatening cancers. The company is headquartered in Knoxville, Tennessee.


Ticker: PVCT
Sector: Health Technology
Industry: Pharmaceuticals: Other
SEC Central Index Key (CIK): 315545
Employees: 2
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals